Company Overview and News

 
Pulilan Celebeer Festival to raise money for surgery of conjoined twins

2018-09-26 newsinfo.inquirer.net
A beer festival is being organized to help separate conjugal twins Klea Ann and Maurice Ann Misa. Photo by Carmela Reyes-Estrope
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

1
San Miguel units complete share-swap deal

2018-09-20 bworldonline - 1
SAN MIGUEL Food and Beverage, Inc. (SMFB) has completed the share-swap transaction consolidating the traditional units of parent San Miguel Corp. (SMC) under its portfolio.
PSKXF SMCP1 SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY PSE GSMI

 
While we’re squabbling over traffic congestion, Vietnam has launched its own car brand

2018-09-18 bworldonline
I’ve been to Vietnam once — about a decade ago, to be exact. At the time, I was pleased that the Philippines still had a more advanced state of transportation, judging by the Vietnamese’s preferred means of getting around. I’m referring to the motorcycle, which ruled the streets of Ho Chi Minh City during my visit like plunderers rule politics. It was my first time to be in a place where motorbikes far outnumbered cars.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

5
Questions on TRAIN 2 a.k.a. TRABAHO

2018-09-16 bworldonline
When the inflation rate of 6.4% for August was finally announced by the Philippine Statistics Authority (PSA) last week, there was a storm of fears that lashed stronger than the most powerful typhoon of the season (Signal No. 4), “Ompong” that trashed northern Philippines and rained heavily the whole weekend on the rest of Luzon.
SMCP1 SMGBF GS GLSSP SMC JBK GSC TFG SMGBY GSJ SMC2B SMC2A SMC2D SMC2C SMC2F SMC2E GJS

2
San Miguel Boosted Further By F&B IPO

2018-09-14 seekingalpha - 2
San Miguel (OTCPK:SMGBY) has seen its stock price surge further on details of the IPO for its food and beverage business. The largest company in the Philippines by sales looks set to expand further as it invests in major infrastructure projects. The stock price has seen tremendous appreciation despite other local stocks seeing a downturn. This downturn has been caused by general anxiety about developing markets and protectionist policies from the Trump administration.
PFP PSKXF SMCP1 PF SMPFY PFP2 SMGBY SMGBF SMC2B HRL SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY PSE GSMI SMPFF

 
Dominguez’s choice: Clark takes precedence over SMC’s aerotropolis

2018-09-12 business.inquirer.net
If Finance Secretary Carlos G. Dominguez III has to choose which the government should prioritize, it will be the development of New Clark City over San Miguel Corp.’s (SMC) proposed P735.6-billion “aerotropolis.”
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
SMC unit plans to import palay

2018-09-12 bworldonline
THE FOOD AND BEVERAGE unit of diversified conglomerate San Miguel Corp. (SMC) said it plans to import unmilled rice should the government pass a law lifting quantitative restrictions (QR) on the volume of rice imports annually.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
PHL vs Iran in FIBA qualifiers match today

2018-09-12 bworldonline
A NEW-LOOK Team Pilipinas takes the cudgels for the country in the FIBA World Cup Asian Qualifiers, taking on Iran today at the start of the second round of the competition.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Regulator to look into minority shareholder’s complaint vs SMC

2018-09-11 bworldonline
THE Securities and Exchange Commission (SEC) has formed a special panel to investigate a complaint filed against San Miguel Corp. (SMC) and its subsidiaries for allegedly violating the mandatory tender offer rule prior to the merger of its traditional businesses.
PFP SMCP1 PF SMPFY PFP2 SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMC2F SMC2E GSMI SMPFF

 
AirAsia joins consortium for Clark O&M bid

2018-09-10 bworldonline
AIRASIA Group Bhd. is joining a consortium, which includes Indonesian airport operator PT Angkasa Pura, that will make a bid for the operations and management (O&M) contract for Clark International Airport in Pampanga.
SMCP1 MPCIY GMQRY GMRINFRA SMGBY 532754 SMGBF FILIY SMC2B SMC2A SMC SMC2D SMC2C MWP MPI MPCFF SMC2F SMC2E FDC MWIDE

 
Sy, Villar lead Forbes’ richest in PH

2018-09-06 newsinfo.inquirer.net
Some of them have grown wealthier despite slower domestic economic growth, higher inflation and the recent stock market downturn.
SVTMF SMCP1 BDOUY SM SECB BDOUF SMGBF SMIVY SMC MWP SBS SPHXF MWIDE SPHZF GMA7 SMGBY SMPH BDO SMC2B SMC2A SMC2D SMC2C SMC2F SPHXY SYBJF SMC2E GNWKY

 
Razon’s ICTSI cornering biggest stake in busiest domestic port

2018-09-06 business.inquirer.net
Billionaire Enrique Razon Jr.’s International Container Terminal Services Inc. (ICTSI) is increasing its stake in Manila North Harbor Port Inc. to 50 percent—a deal that would make ICTSI the single largest shareholder in the country’s biggest domestic port.
ICT SVTMF PSKXF SMCP1 MPCIY SM ICTEF SMGBY SMGBF SMC2B SMIVY SMC2A SMC SMC2D SMC2C MPI MPCFF SMC2F SMC2E PHSXY PSE

 
Villar breaks into Sy-led 10 richest Filipinos list

2018-09-06 bworldonline
HENRY SY, Sr. remains the country’s wealthiest man for the 11th straight year in Forbes Asia’s “Philippines’ 50 Richest” list, which reflected the economy’s overall volatility as many registered shifts in wealth from 2017.
ICT JGSMY GTCAP GTCXY SVTMF NIKL SMCP1 JGS SM ICTEF SECB SMGBF SMIVY SMC ALGGY SBS AGI JGSHF GMA7 SMGBY NIKAY SMC2B SMC2A SMC2D TECH SMC2C SMC2F SYBJF SMC2E ALGGF GNWKY LTG

 
Ayala Corp. CEO senses ‘growing impatience’ with PHL gridlocks

2018-09-06 bworldonline
PHILIPPINE companies can fund President Rodrigo Duterte’s $170-billion infrastructure push while China’s pledges are taking time, Ayala Corp. executive Jose Rene Almendras said.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Manny Villar rises to 2nd spot in Forbes’ rich list

2018-09-06 newsinfo.inquirer.net
Businessman Manuel Villar’s net worth is now at $5 billion (P267.3 billion), according to the newest Philippine rich list published by business magazine Forbes, making him the second richest man in the country.
GMA7 SVTMF SMCP1 SM SMGBY SMGBF SMC2B SMIVY SMC2A SMC SMC2D SMC2C SMC2F SMC2E GNWKY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...